09:57 AM EST - Medicago Inc. : announced the signing of a licensing agreement with Philip Morris Products SA ("PMP"), a subsidiary of Philip Morris International Inc., the leading international tobacco company with products sold in approximately 180 countries. Under the agreement, Medicago grants PMP an exclusive license to develop, commercialize and manufacture Medicago's pandemic and seasonal influenza vaccines for China. In addition, Medicago has signed an exclusive, worldwide license for a portfolio of plant-based protein development technologies from PMP. Medicago Inc.
shares T.MDG are trading up $0.015 at $0.48.
